J. Kevin Buchi - 21 Oct 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc. (AMPE)

Role
Director
Signature
/s/ Dan Stokely, Attorney-in-Fact
Issuer symbol
AMPE
Transactions as of
21 Oct 2021
Transactions value $
$0
Form type
4
Date filed
25 Oct 2021, 10:59
Previous filing
22 Oct 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPE Stock Option (Right to Buy) Award $0 +150K $0.00 150K 21 Oct 2021 Common Stock 150K $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as to 1/36 of the underlying shares monthly on the 13th day of each month for three years (until October 13, 2024). The vesting commencement date is October 13, 2021.